From the Departments of Neurology (E.C.M., A.K.B., M.S.V.E., J.Z.W.), Medicine (N.A.B.), and Obstetrics and Gynecology (R.W.), Columbia University; Department of Epidemiology (A.K.B., M.S.V.E.), Columbia University Mailman School of Public Health, New York, NY; Department of Population Sciences (N.T.C., S.S.W., J.V.L., C.Z.), Beckman Research Institute and City of Hope National Medical Center, Duarte, CA; Department of Neurology (K.L.), University of Minnesota Medical Center, Minneapolis; and Department of Neurology (D.W.), University of Cincinnati Medical Center, OH.
Neurology. 2019 Jan 22;92(4):e305-e316. doi: 10.1212/WNL.0000000000006815. Epub 2018 Dec 26.
To determine whether hypertensive disorders of pregnancy (HDP) increased long-term stroke risk in women in the California Teachers Study (CTS), a prospective cohort study, and whether aspirin or statin use modified this risk.
CTS participants ≤60 years of age at the time of enrollment in 1995 were followed up prospectively for validated stroke outcomes obtained via linkage with California hospital records through December 31, 2015. We calculated unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) for the primary outcomes of all stroke and stroke before 60 years of age among those with and without a history of HDP. We tested for interactions ( < 0.2) and performed stratified analyses to assess the risk of the primary outcomes in women with and without self-reported use of aspirin or statins.
Of 83,749 women included in the analysis, 4,070 (4.9%) had HDP. Women with prior HDP had increased risk of all stroke (adjusted HR 1.3, 95% CI 1.2-1.4) but no increased risk of stroke before age 60 (adjusted HR 1.2, 95% CI 0.9-1.7). There was an interaction ( = 0.18) between aspirin use and HDP history on risk of stroke before age 60: nonusers of aspirin had higher risk (adjusted HR 1.5, 95% CI 1.0-2.1) while aspirin users did not (adjusted HR 0.8, 95% CI 0.4-1.7). This effect was not seen with statins.
After controlling for comorbid conditions, women with prior HDP had increased long-term stroke risk, which was reduced by aspirin use. Randomized trials may be needed to assess whether long-term aspirin use could benefit selected women with a history of HDP.
在加利福尼亚教师研究(CTS)这一前瞻性队列研究中,确定妊娠高血压疾病(HDP)是否会增加女性的长期中风风险,以及阿司匹林或他汀类药物的使用是否会改变这种风险。
在 1995 年入组时年龄≤60 岁的 CTS 参与者,通过与加利福尼亚医院记录的链接,前瞻性地随访验证后的中风结局,截至 2015 年 12 月 31 日。我们计算了有无 HDP 病史的参与者中所有中风和 60 岁前中风的主要结局的未经调整和调整后的风险比(HR)和 95%置信区间(95%CI)。我们进行了交互作用检验(<0.2)和分层分析,以评估有或无阿司匹林或他汀类药物自我报告使用的女性中主要结局的风险。
在纳入分析的 83749 名女性中,有 4070 名(4.9%)患有 HDP。有 HDP 病史的女性发生所有中风的风险增加(调整后的 HR 1.3,95%CI 1.2-1.4),但发生 60 岁前中风的风险没有增加(调整后的 HR 1.2,95%CI 0.9-1.7)。阿司匹林使用和 HDP 病史对 60 岁前中风风险的交互作用(=0.18):阿司匹林非使用者的风险更高(调整后的 HR 1.5,95%CI 1.0-2.1),而阿司匹林使用者的风险则没有增加(调整后的 HR 0.8,95%CI 0.4-1.7)。这种作用在他汀类药物中并未出现。
在控制合并症后,有 HDP 病史的女性长期中风风险增加,而阿司匹林的使用可降低这种风险。可能需要进行随机试验来评估长期使用阿司匹林是否对有 HDP 病史的特定女性有益。